Global Small Interfering RNA (siRNA) Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
This report provides a deep insight into the global Small Interfering RNA (siRNA) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Interfering RNA (siRNA) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Interfering RNA (siRNA) Therapeutics market in any manner.
Global Small Interfering RNA (siRNA) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Market Segmentation (by Type)
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
Market Segmentation (by Application)
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Small Interfering RNA (siRNA) Therapeutics Market
- Overview of the regional outlook of the Small Interfering RNA (siRNA) Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Interfering RNA (siRNA) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Small Interfering RNA (siRNA) Therapeutics
1.2 Key Market Segments
1.2.1 Small Interfering RNA (siRNA) Therapeutics Segment by Type
1.2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Interfering RNA (siRNA) Therapeutics Product Life Cycle
3.3 Global Small Interfering RNA (siRNA) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Interfering RNA (siRNA) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Small Interfering RNA (siRNA) Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Small Interfering RNA (siRNA) Therapeutics Market Competitive Situation and Trends
3.8.1 Small Interfering RNA (siRNA) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Interfering RNA (siRNA) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Small Interfering RNA (siRNA) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Interfering RNA (siRNA) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Small Interfering RNA (siRNA) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Small Interfering RNA (siRNA) Therapeutics Price by Type (2020-2025)
7 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Interfering RNA (siRNA) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
8 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.1.1 Global Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.1.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region
8.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.3.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.4.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.5.2 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.6.2 South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.7.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Small Interfering RNA (siRNA) Therapeutics by Region(2020-2025)
9.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Interfering RNA (siRNA) Therapeutics Production
9.4.1 North America Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Interfering RNA (siRNA) Therapeutics Production
9.5.1 Europe Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Interfering RNA (siRNA) Therapeutics Production (2020-2025)
9.6.1 Japan Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Interfering RNA (siRNA) Therapeutics Production (2020-2025)
9.7.1 China Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GE
10.1.1 GE Basic Information
10.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Overview
10.1.3 GE Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.1.4 GE Business Overview
10.1.5 GE SWOT Analysis
10.1.6 GE Recent Developments
10.2 Horizon Discovery
10.2.1 Horizon Discovery Basic Information
10.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Overview
10.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.2.4 Horizon Discovery Business Overview
10.2.5 Horizon Discovery SWOT Analysis
10.2.6 Horizon Discovery Recent Developments
10.3 Thermo Scientific
10.3.1 Thermo Scientific Basic Information
10.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Overview
10.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.3.4 Thermo Scientific Business Overview
10.3.5 Thermo Scientific SWOT Analysis
10.3.6 Thermo Scientific Recent Developments
10.4 OPKO Health
10.4.1 OPKO Health Basic Information
10.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Overview
10.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.4.4 OPKO Health Business Overview
10.4.5 OPKO Health Recent Developments
10.5 AInylam Pharmaceuticals
10.5.1 AInylam Pharmaceuticals Basic Information
10.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Overview
10.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.5.4 AInylam Pharmaceuticals Business Overview
10.5.5 AInylam Pharmaceuticals Recent Developments
10.6 Arrowhead Research
10.6.1 Arrowhead Research Basic Information
10.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Overview
10.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.6.4 Arrowhead Research Business Overview
10.6.5 Arrowhead Research Recent Developments
10.7 Sanofi Genzyme
10.7.1 Sanofi Genzyme Basic Information
10.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Overview
10.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.7.4 Sanofi Genzyme Business Overview
10.7.5 Sanofi Genzyme Recent Developments
10.8 Genecon Biotechnologies
10.8.1 Genecon Biotechnologies Basic Information
10.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Overview
10.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.8.4 Genecon Biotechnologies Business Overview
10.8.5 Genecon Biotechnologies Recent Developments
10.9 Arbutus Biopharma
10.9.1 Arbutus Biopharma Basic Information
10.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Overview
10.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.9.4 Arbutus Biopharma Business Overview
10.9.5 Arbutus Biopharma Recent Developments
10.10 Silent Therapeutics
10.10.1 Silent Therapeutics Basic Information
10.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Overview
10.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.10.4 Silent Therapeutics Business Overview
10.10.5 Silent Therapeutics Recent Developments
10.11 Sylentis
10.11.1 Sylentis Basic Information
10.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Overview
10.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.11.4 Sylentis Business Overview
10.11.5 Sylentis Recent Developments
11 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast
11.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region
11.2.4 South America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Interfering RNA (siRNA) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Small Interfering RNA (siRNA) Therapeutics by Type (2026-2033)
12.1.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Small Interfering RNA (siRNA) Therapeutics by Type (2026-2033)
12.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Interfering RNA (siRNA) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2024)
Table 10. Global Market Small Interfering RNA (siRNA) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Small Interfering RNA (siRNA) Therapeutics Manufacturing Sites and Area Served
Table 12. Manufacturers Small Interfering RNA (siRNA) Therapeutics Product Type
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Small Interfering RNA (siRNA) Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Small Interfering RNA (siRNA) Therapeutics Sales by Type (K Units)
Table 25. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (M USD)
Table 26. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Type (2020-2025)
Table 27. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2020-2025)
Table 28. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 29. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Type (2020-2025)
Table 30. Global Small Interfering RNA (siRNA) Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 31. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Application
Table 32. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application
Table 33. Global Small Interfering RNA (siRNA) Therapeutics Sales by Application (2020-2025) & (K Units)
Table 34. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2020-2025)
Table 35. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 36. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2020-2025)
Table 37. Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 38. Global Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 39. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region (2020-2025)
Table 40. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 41. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 42. North America Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 43. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 48. South America Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 49. South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 52. Global Small Interfering RNA (siRNA) Therapeutics Production (K Units) by Region(2020-2025)
Table 53. Global Small Interfering RNA (siRNA) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2020-2025)
Table 55. Global Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. GE Basic Information
Table 61. GE Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 62. GE Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. GE Business Overview
Table 64. GE SWOT Analysis
Table 65. GE Recent Developments
Table 66. Horizon Discovery Basic Information
Table 67. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 68. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Horizon Discovery Business Overview
Table 70. Horizon Discovery SWOT Analysis
Table 71. Horizon Discovery Recent Developments
Table 72. Thermo Scientific Basic Information
Table 73. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 74. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Thermo Scientific Business Overview
Table 76. Thermo Scientific SWOT Analysis
Table 77. Thermo Scientific Recent Developments
Table 78. OPKO Health Basic Information
Table 79. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 80. OPKO Health Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. OPKO Health Business Overview
Table 82. OPKO Health Recent Developments
Table 83. AInylam Pharmaceuticals Basic Information
Table 84. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 85. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. AInylam Pharmaceuticals Business Overview
Table 87. AInylam Pharmaceuticals Recent Developments
Table 88. Arrowhead Research Basic Information
Table 89. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 90. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Arrowhead Research Business Overview
Table 92. Arrowhead Research Recent Developments
Table 93. Sanofi Genzyme Basic Information
Table 94. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 95. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Sanofi Genzyme Business Overview
Table 97. Sanofi Genzyme Recent Developments
Table 98. Genecon Biotechnologies Basic Information
Table 99. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 100. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Genecon Biotechnologies Business Overview
Table 102. Genecon Biotechnologies Recent Developments
Table 103. Arbutus Biopharma Basic Information
Table 104. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 105. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Arbutus Biopharma Business Overview
Table 107. Arbutus Biopharma Recent Developments
Table 108. Silent Therapeutics Basic Information
Table 109. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 110. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Silent Therapeutics Business Overview
Table 112. Silent Therapeutics Recent Developments
Table 113. Sylentis Basic Information
Table 114. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 115. Sylentis Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Sylentis Business Overview
Table 117. Sylentis Recent Developments
Table 118. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Small Interfering RNA (siRNA) Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Small Interfering RNA (siRNA) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Interfering RNA (siRNA) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Product Life Cycle
Figure 13. Small Interfering RNA (siRNA) Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Small Interfering RNA (siRNA) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Small Interfering RNA (siRNA) Therapeutics
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market PEST Analysis
Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Small Interfering RNA (siRNA) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Small Interfering RNA (siRNA) Therapeutics by Type in 2024
Figure 29. Market Size Share of Small Interfering RNA (siRNA) Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Small Interfering RNA (siRNA) Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application
Figure 33. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application in 2024
Figure 37. Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Interfering RNA (siRNA) Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Interfering RNA (siRNA) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Interfering RNA (siRNA) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Application (2026-2033)
1.1 Market Definition and Statistical Scope of Small Interfering RNA (siRNA) Therapeutics
1.2 Key Market Segments
1.2.1 Small Interfering RNA (siRNA) Therapeutics Segment by Type
1.2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Interfering RNA (siRNA) Therapeutics Product Life Cycle
3.3 Global Small Interfering RNA (siRNA) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Interfering RNA (siRNA) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Small Interfering RNA (siRNA) Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Small Interfering RNA (siRNA) Therapeutics Market Competitive Situation and Trends
3.8.1 Small Interfering RNA (siRNA) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Interfering RNA (siRNA) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Small Interfering RNA (siRNA) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Interfering RNA (siRNA) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Small Interfering RNA (siRNA) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Small Interfering RNA (siRNA) Therapeutics Price by Type (2020-2025)
7 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Interfering RNA (siRNA) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
8 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.1.1 Global Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.1.2 Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region
8.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.3.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.4.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.5.2 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Interfering RNA (siRNA) Therapeutics Sales by Country
8.6.2 South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales by Region
8.7.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Small Interfering RNA (siRNA) Therapeutics by Region(2020-2025)
9.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Interfering RNA (siRNA) Therapeutics Production
9.4.1 North America Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Interfering RNA (siRNA) Therapeutics Production
9.5.1 Europe Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Interfering RNA (siRNA) Therapeutics Production (2020-2025)
9.6.1 Japan Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Interfering RNA (siRNA) Therapeutics Production (2020-2025)
9.7.1 China Small Interfering RNA (siRNA) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Small Interfering RNA (siRNA) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GE
10.1.1 GE Basic Information
10.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Overview
10.1.3 GE Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.1.4 GE Business Overview
10.1.5 GE SWOT Analysis
10.1.6 GE Recent Developments
10.2 Horizon Discovery
10.2.1 Horizon Discovery Basic Information
10.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Overview
10.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.2.4 Horizon Discovery Business Overview
10.2.5 Horizon Discovery SWOT Analysis
10.2.6 Horizon Discovery Recent Developments
10.3 Thermo Scientific
10.3.1 Thermo Scientific Basic Information
10.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Overview
10.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.3.4 Thermo Scientific Business Overview
10.3.5 Thermo Scientific SWOT Analysis
10.3.6 Thermo Scientific Recent Developments
10.4 OPKO Health
10.4.1 OPKO Health Basic Information
10.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Overview
10.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.4.4 OPKO Health Business Overview
10.4.5 OPKO Health Recent Developments
10.5 AInylam Pharmaceuticals
10.5.1 AInylam Pharmaceuticals Basic Information
10.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Overview
10.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.5.4 AInylam Pharmaceuticals Business Overview
10.5.5 AInylam Pharmaceuticals Recent Developments
10.6 Arrowhead Research
10.6.1 Arrowhead Research Basic Information
10.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Overview
10.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.6.4 Arrowhead Research Business Overview
10.6.5 Arrowhead Research Recent Developments
10.7 Sanofi Genzyme
10.7.1 Sanofi Genzyme Basic Information
10.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Overview
10.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.7.4 Sanofi Genzyme Business Overview
10.7.5 Sanofi Genzyme Recent Developments
10.8 Genecon Biotechnologies
10.8.1 Genecon Biotechnologies Basic Information
10.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Overview
10.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.8.4 Genecon Biotechnologies Business Overview
10.8.5 Genecon Biotechnologies Recent Developments
10.9 Arbutus Biopharma
10.9.1 Arbutus Biopharma Basic Information
10.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Overview
10.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.9.4 Arbutus Biopharma Business Overview
10.9.5 Arbutus Biopharma Recent Developments
10.10 Silent Therapeutics
10.10.1 Silent Therapeutics Basic Information
10.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Overview
10.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.10.4 Silent Therapeutics Business Overview
10.10.5 Silent Therapeutics Recent Developments
10.11 Sylentis
10.11.1 Sylentis Basic Information
10.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Overview
10.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Market Performance
10.11.4 Sylentis Business Overview
10.11.5 Sylentis Recent Developments
11 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast
11.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region
11.2.4 South America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Interfering RNA (siRNA) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Small Interfering RNA (siRNA) Therapeutics by Type (2026-2033)
12.1.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Small Interfering RNA (siRNA) Therapeutics by Type (2026-2033)
12.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Interfering RNA (siRNA) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2024)
Table 10. Global Market Small Interfering RNA (siRNA) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Small Interfering RNA (siRNA) Therapeutics Manufacturing Sites and Area Served
Table 12. Manufacturers Small Interfering RNA (siRNA) Therapeutics Product Type
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Small Interfering RNA (siRNA) Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Small Interfering RNA (siRNA) Therapeutics Sales by Type (K Units)
Table 25. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (M USD)
Table 26. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Type (2020-2025)
Table 27. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2020-2025)
Table 28. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 29. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Type (2020-2025)
Table 30. Global Small Interfering RNA (siRNA) Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 31. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) by Application
Table 32. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application
Table 33. Global Small Interfering RNA (siRNA) Therapeutics Sales by Application (2020-2025) & (K Units)
Table 34. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2020-2025)
Table 35. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 36. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2020-2025)
Table 37. Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 38. Global Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 39. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region (2020-2025)
Table 40. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 41. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 42. North America Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 43. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 48. South America Small Interfering RNA (siRNA) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 49. South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 52. Global Small Interfering RNA (siRNA) Therapeutics Production (K Units) by Region(2020-2025)
Table 53. Global Small Interfering RNA (siRNA) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2020-2025)
Table 55. Global Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Small Interfering RNA (siRNA) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. GE Basic Information
Table 61. GE Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 62. GE Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. GE Business Overview
Table 64. GE SWOT Analysis
Table 65. GE Recent Developments
Table 66. Horizon Discovery Basic Information
Table 67. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 68. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Horizon Discovery Business Overview
Table 70. Horizon Discovery SWOT Analysis
Table 71. Horizon Discovery Recent Developments
Table 72. Thermo Scientific Basic Information
Table 73. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 74. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Thermo Scientific Business Overview
Table 76. Thermo Scientific SWOT Analysis
Table 77. Thermo Scientific Recent Developments
Table 78. OPKO Health Basic Information
Table 79. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 80. OPKO Health Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. OPKO Health Business Overview
Table 82. OPKO Health Recent Developments
Table 83. AInylam Pharmaceuticals Basic Information
Table 84. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 85. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. AInylam Pharmaceuticals Business Overview
Table 87. AInylam Pharmaceuticals Recent Developments
Table 88. Arrowhead Research Basic Information
Table 89. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 90. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Arrowhead Research Business Overview
Table 92. Arrowhead Research Recent Developments
Table 93. Sanofi Genzyme Basic Information
Table 94. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 95. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Sanofi Genzyme Business Overview
Table 97. Sanofi Genzyme Recent Developments
Table 98. Genecon Biotechnologies Basic Information
Table 99. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 100. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Genecon Biotechnologies Business Overview
Table 102. Genecon Biotechnologies Recent Developments
Table 103. Arbutus Biopharma Basic Information
Table 104. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 105. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Arbutus Biopharma Business Overview
Table 107. Arbutus Biopharma Recent Developments
Table 108. Silent Therapeutics Basic Information
Table 109. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 110. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Silent Therapeutics Business Overview
Table 112. Silent Therapeutics Recent Developments
Table 113. Sylentis Basic Information
Table 114. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Overview
Table 115. Sylentis Small Interfering RNA (siRNA) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Sylentis Business Overview
Table 117. Sylentis Recent Developments
Table 118. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Small Interfering RNA (siRNA) Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Small Interfering RNA (siRNA) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Small Interfering RNA (siRNA) Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Interfering RNA (siRNA) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Product Life Cycle
Figure 13. Small Interfering RNA (siRNA) Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Small Interfering RNA (siRNA) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Small Interfering RNA (siRNA) Therapeutics
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market PEST Analysis
Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Small Interfering RNA (siRNA) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Small Interfering RNA (siRNA) Therapeutics by Type in 2024
Figure 29. Market Size Share of Small Interfering RNA (siRNA) Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Small Interfering RNA (siRNA) Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application
Figure 33. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application in 2024
Figure 37. Global Small Interfering RNA (siRNA) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Interfering RNA (siRNA) Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Small Interfering RNA (siRNA) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Interfering RNA (siRNA) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Interfering RNA (siRNA) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Small Interfering RNA (siRNA) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Small Interfering RNA (siRNA) Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Application (2026-2033)
